Advertisement
OtherArticle

Inhibitory actions of potentiating neuroactive steroids in the human α1β3γ2L GABAA receptor

Spencer R. Pierce, Allison L. Germann, Douglas F Covey, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
Molecular Pharmacology August 30, 2024, MOLPHARM-AR-2024-000960; DOI: https://doi.org/10.1124/molpharm.124.000960
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherArticle

GABAA receptor inhibition by potentiating steroids

Spencer R. Pierce, Allison L. Germann, Douglas F Covey, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
Molecular Pharmacology August 30, 2024, MOLPHARM-AR-2024-000960; DOI: https://doi.org/10.1124/molpharm.124.000960
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement